Key Highlights

  • FMC closed at $5.62 on October 15, down 30.53% on the session.
  • The company cut its third-quarter outlook, and shares fell after the update.
  • The update includes a $625 million to $675 million impact from commercial actions.
  • The decline extends a heavy slide through 2026 for the crop-protection maker.

FMC Corporation (NYSE:FMC) stood apart from the rest of Thursday's selling tape during the October 15, 2026 US regular session. Most of the day's steepest decliners were swept up in a sector-wide rout across artificial-intelligence and semiconductor shares, but FMC fell after a company-specific update. The stock closed at $5.62, down 30.53%, one of the largest single-day losses on the US tape.

Third-Quarter Outlook Reduced

The catalyst was a sharp reduction to the company's own guidance. FMC cut its third-quarter outlook, with revenue now expected between $65 million and $125 million and adjusted EBITDA between negative $565 million and negative $510 million. The estimates include a $625 million to $675 million impact tied to commercial actions to lower prices on select products held by channel customers and to change the selling and pricing model in the United States.

A downward revision of that scale, disclosed outside the ordinary cadence of a scheduled report, forced a rapid repricing, and the 30.53% decline followed the update. Management pointed to weaker third-quarter demand and elevated inventory of higher-priced products held by channel customers, which limits product movement and replenishment.

A Long Slide Through 2026

FMC is an agricultural-sciences company, a maker of crop-protection chemistries and related products serving growers around the world. It is not a penny stock by nature, and the $5.62 close is not a data error. Rather, it is the endpoint of a long and punishing slide through 2026, against a backdrop that included a reset of its guidance and a broader strategic review of the business.

Thursday's drop extended an existing downtrend and landed on a share price that had already been compressed by months of deteriorating sentiment. The cumulative effect is a valuation far below where the company traded earlier in its history.

FMC belongs to none of the day's marquee buckets. The session's main story was a deepening sell-off in AI-linked and semiconductor names, with the Philadelphia Semiconductor Index extending a multi-session losing streak, while defensive areas such as healthcare and consumer staples drew a rotation bid.

What the FMC Drop Signals

Open questions remain over how the revised numbers translate into the fuller picture when more detail arrives, and over how the ongoing strategic review ultimately resolves.

FMC's 30.53% drop to $5.62 followed a sharply lowered quarterly outlook and a $625 million to $675 million impact from commercial actions, layered on top of a stock that had already endured a severe 2026 decline.